Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / REGN - Regeneron multiple myeloma therapy granted FDA priority review

REGN - Regeneron multiple myeloma therapy granted FDA priority review

Regeneron Pharmaceuticals Inc.

2024-02-21 08:14:13 ET

Regeneron ( NASDAQ: REGN ) announced Wednesday that the FDA granted priority review for its Biologics License Application (BLA) seeking U.S. market access for its multiple myeloma therapy linvoseltamab....

For further details see:

Regeneron multiple myeloma therapy granted FDA priority review
Stock Information
Company Name: Regeneron Pharmaceuticals Inc.
Stock Symbol: REGN
Market: NASDAQ
Website: regeneron.com
Menu
REGN REGN Quote REGN Short REGN News REGN Articles REGN Message Board
Get REGN Alerts

News, Short Squeeze, Breakout and More Instantly...